We are monitoring the impact of COVID-19 on Europe Insulin Pump Market Get in touch with us for detailed analysis Know More
Pulished Date March, 2021
ID: 11303
Share on
Share on

Europe Insulin Pump Market Research Report – Segmented By Type, End User and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: March, 2021
ID: 11303
Pages: 100

Europe Insulin Pump Market Size (2020 to 2025)

As per our report, the European insulin pump market size is forecasted to worth USD 3.12 Billion by 2025.

Y-O-Y growth in the aging population and growing advanced technologies in the insulin pumps, and rising incidences of chronic diseases are majorly accelerating the European insulin pumps market. The EU governments take the growing awareness in early diagnosis and treatment of diabetes increases, growing obesity, and mushrooming initiatives further promote the European insulin pumps market. According to the International Diabetes Federation (IDF), around 384 million people were diagnosed with diabetes in 2013. By the end of 2035, the count is projected to reach 592 million.

Numerous new product launches have been happening by the European insulin pump manufacturers promptly, which is expected to increase the adoption and market expansion during the forecast period. The snowballing demand for insulin pumps and compounding adoption of diabetes patients over conventional techniques offer growth opportunities for the insulin pump market growth in Europe.

However, factors such as the expensive nature of insulin pumps, lack of reimbursement policies, and easy availability of alternate treatment options hamper the market growth. The climbing tendency towards naturopathy is an essential factor diminishing the market growth. 

Impact of COVID-19 on the European Insulin Pump Market:

The SARS-CoV-2 reagent is responsible for the cause of novel coronavirus (COVID 19) and was declared a pandemic by the World Health Organization (WHO) in March 2020. The COVID 19 has affected the insulin pump market negatively. The increasing number of diabetic patients results in high pump usage, associated with boosting insulin pumps market sales. Diabetic patients hunt for healthcare products in different ways like hospital pharmacies, online portals, and emergency medical shops. The COVID-19 crisis has had a massive hit on medical devices. With continued access to necessary medicines, technologies, and treatment, the smart insulin manufacturing industries are taking specific measures to make the product available, which have supplied well to the market's growth. 

This research report on the European insulin pump market has been segmented and sub-segmented into the following categories:

By Pump Type:

  • Traditional
  • Disposable

By End User:

  • Hospitals & Clinics
  • Homecare
  • Laboratories
  • Others

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, the European insulin pumps market is predicted to grow at a CAGR of 6.40% from 2020 to 2025 due to the growing incidence of diabetes among all age groups, increasing obesity in people, and unhealthy diets among the patients. An estimated 53 million had diagnosed with diabetes in Europe due to lifestyle changes, obesity, and unhealthy diet. The growing number of diabetic patients, increasing older people, and intensifying insulin pumps' advancements escalate the region's insulin pumps market growth. According to the World Health Organization (WHO) estimated 30-70% of adults are obese, affecting 10-30% of adults in Europe. 

The German insulin pump market is currently leading the European market and estimated to account for a market share of 34% during the forecast period due to the favorable reimbursement policies, growing awareness regarding an insulin pump's advantages, increasing per capita income, and advanced diabetes infrastructure. Factors like increasing diabetes population, diabetes type 1 patients, and developed reimbursement policies escalate the insulin pumps market growth throughout the estimated period. 

The U.K insulin pump market is expected to have the fastest growth rate with a CAGR during the assessment period. With the high adoption among the diabetes population over conventional techniques, many insulin pump manufacturers and new product launches heighten market development. Around 4million have type 1 diabetes, and 549000 people were diagnosed in the U.K in 2019. 

The Italian insulin pump market is predicted to account for a substantial market share in the European market during the forecast period. More than 2 million people with type 2 diabetes and surge the development of insulin delivery devices during the forecast period. National Congress Italian Society metabolism diabetes society has released a V-Go wearable insulin delivery device to treat type 2 diabetes. 

Animus Corporation, Asante, Cellnovo Ltd., Insulet Corporation, Medtronics, Inc., Nipro Diagnostic, Inc., Ypsomed, Roche, Sooil Development Co., Ltd., and Tandem Diabetes Care, Inc. are some of the noteworthy companies in the European market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Type
      1. Traditional Insulin Pumps
      2. Disposable Insulin Pumps
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By End User
      1. Hospitals & Clinics
      2. Homecare
      3. Laboratories
      4. Others
      5. Y-o-Y Growth Analysis, By End User
      6. Market Attractiveness Analysis, By End User
      7. Market Share Analysis, By End User
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends       
      2. Impact Analysis        
      3. Y-o-Y Growth Analysis            
        1. By Geographical Area
        2. By Type
        3. By End User
      4. Market Attractiveness Analysis          
        1. By Geographical Area
        2. By Type
        3. By End User
      5.          Market Share Analysis   
        1. By Geographical Area
        2. By Type
        3. By End User
    2. Asia-Pacific
      1. Introduction
      2. United Kingdom
      3. Germany
      4. France
      5. Spain
      6. Italy
      7. Rest of Europe
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Animus Corporation (U.S.)
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Asante (U.S.)
    3. Cellnovo Ltd. (U.K.)
    4. Insulet Corporation (U.S.)
    5. Medtronics, Inc. (U.S.)
    6. Nipro Diagnostic, Inc. (Japan)
    7. Ypsomed (Switzerland)
    8. Roche (Switzerland)
    9. Sooil Development Co., Ltd. (Korea)
    10. Tandem Diabetes Care, Inc. (U.S.)
  9. Competitive Landscape
    1. Merger and Acquisition Analysis
    2. Agreements, Collaborations and Joint Ventures
    3. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of pump type and end-user, along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Global Insulin Pump Market By Pump Type, From 2020 to 2025 (USD Million)
  2. Europe Traditional Market By Region, From 2020 to 2025 (USD Million)
  3. Europe Disposable Market By Region, From 2020 to 2025 (USD Million)
  4. Europe Global Insulin Pump Market By End User, From 2020 to 2025 (USD Million)
  5. Europe Hospitals & Clinics Market By Region, From 2020 to 2025 (USD Million)
  6. Europe HomeCare Market By Region, From 2020 to 2025 (USD Million)
  7. Europe Laboratories Market By Region, From 2020 to 2025 (USD Million)
  8. Europe Others Market By Region, From 2020 to 2025 (USD Million)
  9. U.K. Global Insulin Pump Market By Pump Type, From 2020 to 2025 (USD Million)
  10. U.K. Global Insulin Pump Market By End User, From 2020 to 2025 (USD Million)
  11. Germany Global Insulin Pump Market By Pump Type, From 2020 to 2025 (USD Million)
  12. Germany Global Insulin Pump Market By End User, From 2020 to 2025 (USD Million)
  13. France Global Insulin Pump Market By Pump Type, From 2020 to 2025 (USD Million)
  14. France Global Insulin Pump Market By End User, From 2020 to 2025 (USD Million)
  15. Italy Global Insulin Pump Market By Pump Type, From 2020 to 2025 (USD Million)
  16. Italy Global Insulin Pump Market By End User, From 2020 to 2025 (USD Million)
  17. Spain Global Insulin Pump Market By Pump Type, From 2020 to 2025 (USD Million)
  18. Spain Global Insulin Pump Market By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample